These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. New-Onset Diabetes Mellitus, Hypertension, Dyslipidaemia as Sequelae of COVID-19 Infection-Systematic Review. Wrona M; Skrypnik D Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36293857 [TBL] [Abstract][Full Text] [Related]
4. Downregulation of microRNA-146a in diabetes, obesity and hypertension may contribute to severe COVID-19. Roganović J Med Hypotheses; 2021 Jan; 146():110448. PubMed ID: 33338955 [TBL] [Abstract][Full Text] [Related]
5. Prediction of Post-Acute-Sequelae of COVID-19 by Cargo Protein Biomarkers of Blood Total Extracellular Vesicles in Acute COVID-19. Goetzl EJ; Yao PJ; Kapogiannis D Am J Med; 2023 Aug; 136(8):824-829. PubMed ID: 37072092 [TBL] [Abstract][Full Text] [Related]
6. Persistent Circulating Severe Acute Respiratory Syndrome Coronavirus 2 Spike Is Associated With Post-acute Coronavirus Disease 2019 Sequelae. Swank Z; Senussi Y; Manickas-Hill Z; Yu XG; Li JZ; Alter G; Walt DR Clin Infect Dis; 2023 Feb; 76(3):e487-e490. PubMed ID: 36052466 [TBL] [Abstract][Full Text] [Related]
7. New-onset type 1 diabetes in children and adolescents as postacute sequelae of SARS-CoV-2 infection: A systematic review and meta-analysis of cohort studies. Rahmati M; Yon DK; Lee SW; Udeh R; McEVoy M; Kim MS; Gyasi RM; Oh H; López Sánchez GF; Jacob L; Li Y; Koyanagi A; Shin JI; Smith L J Med Virol; 2023 Jun; 95(6):e28833. PubMed ID: 37264687 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of MicroRNA Expression Pattern (miR-28, miR-181a, miR-34a, and miR-31) in Patients with COVID-19 Admitted to ICU and Diabetic COVID-19 Patients. Khatami A; Taghizadieh M; Sadri Nahand J; Karimzadeh M; Kiani SJ; Khanaliha K; Kalantari S; Chavoshpour S; Mirzaei H; Donyavi T; Bokharaei-Salim F Intervirology; 2023; 66(1):63-76. PubMed ID: 36882006 [TBL] [Abstract][Full Text] [Related]
9. ACE Gene Variants Rise the Risk of Severe COVID-19 in Patients With Hypertension, Dyslipidemia or Diabetes: A Spanish Pilot Study. Íñiguez M; Pérez-Matute P; Villoslada-Blanco P; Recio-Fernandez E; Ezquerro-Pérez D; Alba J; Ferreira-Laso ML; Oteo JA Front Endocrinol (Lausanne); 2021; 12():688071. PubMed ID: 34489863 [TBL] [Abstract][Full Text] [Related]
10. Is diabetes mellitus a risk factor for COronaVIrus Disease 19 (COVID-19)? Pugliese G; Vitale M; Resi V; Orsi E Acta Diabetol; 2020 Nov; 57(11):1275-1285. PubMed ID: 32865671 [TBL] [Abstract][Full Text] [Related]
11. Dynamics of the Microbiota and Its Relationship with Post-COVID-19 Syndrome. Moreno-Corona NC; López-Ortega O; Pérez-Martínez CA; Martínez-Castillo M; De Jesús-González LA; León-Reyes G; León-Juárez M Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834270 [TBL] [Abstract][Full Text] [Related]
12. Longitudinal NMR-Based Metabolomics Study Reveals How Hospitalized COVID-19 Patients Recover: Evidence of Dyslipidemia and Energy Metabolism Dysregulation. Ansone L; Rovite V; Brīvība M; Jagare L; Pelcmane L; Borisova D; Thews A; Leiminger R; Kloviņš J Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338803 [TBL] [Abstract][Full Text] [Related]
13. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924 [TBL] [Abstract][Full Text] [Related]
14. Persistent circulation of soluble and extracellular vesicle-linked Spike protein in individuals with postacute sequelae of COVID-19. Craddock V; Mahajan A; Spikes L; Krishnamachary B; Ram AK; Kumar A; Chen L; Chalise P; Dhillon NK J Med Virol; 2023 Feb; 95(2):e28568. PubMed ID: 36756925 [TBL] [Abstract][Full Text] [Related]
15. Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Are Associated With Reduced Risk of SARS-CoV-2 Infection Without Comorbidities Including Diabetes, Hypertension, and Dyslipidemia: A Propensity Score-Matched Nationwide Cohort Study. Kim B; Jung JH; Han K; Kang S; Lee E; Chung H; Kim SG; Cho SJ J Korean Med Sci; 2023 Apr; 38(13):e99. PubMed ID: 37012686 [TBL] [Abstract][Full Text] [Related]
16. Increased circulating microparticles contribute to severe infection and adverse outcomes of COVID-19 in patients with diabetes. Sun H; Du Y; Kumar R; Buchkovich N; He P Am J Physiol Heart Circ Physiol; 2022 Dec; 323(6):H1176-H1193. PubMed ID: 36269646 [TBL] [Abstract][Full Text] [Related]
17. COVID-19 Vaccination Prior to SARS-CoV-2 Infection Reduced Risk of Subsequent Diabetes Mellitus: A Real-World Investigation Using U.S. Electronic Health Records. Hsieh TYJ; Chang R; Yong SB; Liao PL; Hung YM; Wei JC Diabetes Care; 2023 Dec; 46(12):2193-2200. PubMed ID: 37851392 [TBL] [Abstract][Full Text] [Related]
18. Long COVID brain fog and muscle pain are associated with longer time to clearance of SARS-CoV-2 RNA from the upper respiratory tract during acute infection. Antar AAR; Yu T; Demko ZO; Hu C; Tornheim JA; Blair PW; Thomas DL; Manabe YC Front Immunol; 2023; 14():1147549. PubMed ID: 37187756 [TBL] [Abstract][Full Text] [Related]
19. Pathogenesis-directed therapy of 2019 novel coronavirus disease. Stratton CW; Tang YW; Lu H J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355 [TBL] [Abstract][Full Text] [Related]
20. COVID-19 in patients with rheumatological diseases in the Eastern Province of Saudi Arabia. Alqatari S; Nemer A; Hasan M; Bukhari R; Al Argan R; Al Khafaji D; Alwaheed A; Alzaki A; Al-Wazza M; Al Warthan S; Al Saeed A; Albeladi F; Almeer H; AlSulaiman R; Abu Quren A J Med Life; 2023 Jun; 16(6):873-882. PubMed ID: 37675163 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]